GBCS Insider Trading Activity and SEC Form 4 Filings
GBCS insider trading summary
Over the past 12 months, insiders at Selectis Health, Inc. (GBCS) reported 1 open-market purchase worth $14K by 1 insider and no sales on SEC Form 4. Net insider buying was $14K.
Latest GBCS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 18, 2025 | Lance Baller | Director | Buy | $14K (6,192 @ $2.20) |
| Oct 6, 2022 | Lance Baller | CEO | Buy | $2K (400 @ $6.00) |
| Oct 6, 2022 | Lance Baller | CEO | Buy | $580 (100 @ $5.80) |
| Jul 9, 2021 | Clifford L Esq Neuman | Director | Buy | $50K (100,000 @ $0.50) |
| Jul 9, 2021 | Christopher R. Barker | President and COO | Buy | $25K (50,000 @ $0.50) |
| Jul 9, 2021 | Brandon Thall | CFO | Buy | $10K (20,000 @ $0.50) |
| Dec 20, 2017 | Andrew L Sink | Director | Buy | $32 (70 @ $0.45) |
| Dec 20, 2017 | Andrew L Sink | Director | Buy | $12K (24,930 @ $0.50) |
| Dec 19, 2017 | Andrew L Sink | Director | Buy | $13K (30,000 @ $0.43) |
| Dec 19, 2017 | Andrew L Sink | Director | Buy | $1K (3,000 @ $0.45) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.